Preventive Strategies for Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Procedures: Evidence From a Hierarchical Bayesian Network Meta-Analysis of 124 Trials and 28 240 Patients [Coronary Interventions]
Conclusions—
In patients undergoing percutaneous coronary procedures, statin administration is associated with a marked and consistent reduction in the risk of CIAKI compared with saline. Although xanthine, NAC, NaHCO3, NAC+NaHCO3, ischemic preconditioning, and natriuretic peptide may have nephroprotective effects, these results were not consistent across multiple sensitivity analyses.
Source: Circulation: Cardiovascular Interventions - Category: Cardiology Authors: Giacoppo, D., Gargiulo, G., Buccheri, S., Aruta, P., Byrne, R. A., Cassese, S., Dangas, G., Kastrati, A., Mehran, R., Tamburino, C., Capodanno, D. Tags: Percutaneous Coronary Intervention Coronary Interventions Source Type: research
More News: Acetylcysteine | Angioplasty | Cardiology | Cardiovascular | Cholesterol | Coronary Angioplasty | Diabetes | Diabetes Mellitus | Endocrinology | Heart | Percutaneous Coronary Intervention | Statin Therapy | Study | Urology & Nephrology